Clinical Trial Update: Can Levothyroxine Treatment Reduce the Development of Cardio-metabolic Disorder in Subclinical Hypothyroidism? [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial exploring whether levothyroxine can reduce the development of cardio-metabolic disorders in subclinical hypothyroidism, with status currently un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subclinical Hypothyroidism

Drugs mentioned

• Levothyroxine (levothyroxine)

Snippet

Sponsor: Ain Shams University | Conditions: Subclinical hypothyroïdism | Phase 1, Phase 2 | Status: UNKNOWN